Drospirenone And Ethinyl Estradiol Kit
Product Images NDC 68180-868

This appears to be a list of different studies that use different methods (Hazard Ratio, Rate Ratio, and Odds Ratio) to determine the risk or association of certain factors with nonfatal idiopathic cases. The list includes studies from different countries and sectors (FDA-funded, Danish re-analysis, German case-control) including prospective cohort and case-control studies. It is unclear what the numbers at the end represent.*

This is a table displaying the number of women with blood clots out of 10,000 women years based on their status as a Non-COC (combined oral contraceptive) user, COC user, pregnant, or postpartum (12 weeks only). The pregnancy data is based on the actual duration of pregnancy in reference studies, with the assumption that pregnancy lasts nine months. The rate of blood clots during pregnancy is 7 to 27 per 10,000 women years.*

Drospirenone Ethinyl estradiol is a combination of hormones used as a birth control pill to prevent pregnancy.*

This text describes different rates of pregnancy per 100 women in one year, depending on the form of birth control used. It lists different types of birth control, such as implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, spermicide, withdrawal, and no birth control. These methods can prevent pregnancy by reducing fertility or by preventing the sperm from reaching the egg. Some options mentioned have varying rates of effectiveness, such as no birth control, which is the riskiest, versus implants or sterilization, which is the most effective. The text provides some numbers to help illustrate the effectiveness of each method.*

This appears to be a chart showing the number of women with blood clots out of 10,000 women years for different categories including non-pregnant Rargestom, non-COC user L, and postpartum Rang (limited to 12 weeks). The pregnancy data is based on actual duration of pregnancy in reference studies and assumes a gestation period of 9 months, resulting in a rate of 7 to 27 per 10,000 women years.*